A therapy for European patent term extensions: the <i>Neurim</i> case and supplementary protection certificates for "new therapeutic applications" *

European Union - July 30 2012
On July 19, 2012, the Court of Justice of the European Union ("CJEU") issued its long-awaited decision in case C-130/11 Neurim Pharmaceuticals (1991) Ltd v. Comptroller-General of Patents.

Co-authors: Dr. Christian B. Fulda, Roland J. Graf.

---

Europe's highest court decides on patent term extensions for fixed-combination medicinal products *

European Union, United Kingdom - December 21 2011
Several national patent term extension proceedings regarding fixed-combination medicinal products have been stayed in Europe since UK courts have referred two cases to the highest European court—the Court of Justice of the European Union.

Co-authors: Dr. Christian B. Fulda, Christiane S. Schweizer , Dr. Niklas Piening , Christian Paul.

---

Europe's landmark decision on stem cell patents, or: the strict European view on life *

European Union - October 31 2011
In a landmark decision on October 18, 2011, the highest court of the European Union—the Court of Justice—decided on the patentability of stem-cell-related inventions (case number C-34/10).

Co-authors: Dr. Niklas Piening , Christian Paul.

---

Patent term extension for medical devices: new opportunities, open questions *

Germany - February 15 2011
The first German patent term extension granted for a medical device, a combination product, may open the door for extended patent protection for combination products.

Co-authors: Dr. Christian B. Fulda, Dr. Niklas Piening .

---

No clear pointer in the right direction: validity issues in Europe of patent term extensions covering fixed-combination medicinal products *

European Union - February 8 2011
Pitfalls loom when applying for patent term extensions covering fixed combination medicinal products.

Co-authors: Dr. Christian B. Fulda, Dr. Niklas Piening .

---